MovDisordV3, PascalFrancis, Curation, bibRecord, 003520

Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease : A study with positron emission tomography and [11C]raclopride

Identifieur interne : 003520 ( PascalFrancis/Curation ); précédent : 003519; suivant : 003521

Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease : A study with positron emission tomography and [11C]raclopride

Auteurs : A. Antonini [Suisse] ; J. Schwarz [Suisse] ; W. H. Oertel [Suisse] ; O. Pogarell [Suisse] ; K. L. Leenders [Suisse, Allemagne]

Source :

Movement disorders [ 0885-3185 ] ; 1997.

RBID : Pascal:97-0142918

Descripteurs français

Pascal (Inist)
- Parkinson maladie, Récepteur dopaminergique D2, Corps strié, Tomoscintigraphie, Positon, Raclopride, Neuroleptique, Psychotrope, Antagoniste dopamine, Exploration, Homme, Long terme.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Corpus striatum, D2 Dopamine receptor, Dopamine antagonist, Emission tomography, Exploration, Human, Long term, Neuroleptic, Parkinson disease, Positron, Psychotropic, Raclopride.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 12`
A06				`@2 1`
A08	`01`	`1`	`ENG`	`@1 Long-term changes of striatal dopamine D₂ receptors in patients with Parkinson's disease : A study with positron emission tomography and [¹¹C]raclopride`
A11	`01`	`1`		`@1 ANTONINI (A.)`
A11	`02`	`1`		`@1 SCHWARZ (J.)`
A11	`03`	`1`		`@1 OERTEL (W. H.)`
A11	`04`	`1`		`@1 POGARELL (O.)`
A11	`05`	`1`		`@1 LEENDERS (K. L.)`
A14	`01`			`@1 PET Department, Paul Scherrer Institute @2 Villigen @3 CHE @Z 1 aut. @Z 5 aut.`
A14	`02`			`@1 Department of Neurology, University Hospital Zurich @2 Zurich @3 CHE @Z 2 aut. @Z 3 aut. @Z 4 aut.`
A14	`03`			`@1 Department of Neurology, Klinikum Grosshadern, Ludowig-Maximilians University @2 Munich @3 DEU @Z 5 aut.`
A20				`@1 33-38`
A21				`@1 1997`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000062292810050`
A44				`@0 0000 @1 © 1997 INIST-CNRS. All rights reserved.`
A45				`@0 23 ref.`
A47	`01`	`1`		`@0 97-0142918`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C02	`01`	`X`		`@0 002B17G`
C03	`01`	`X`	`FRE`	`@0 Parkinson maladie @5 01`
C03	`01`	`X`	`ENG`	`@0 Parkinson disease @5 01`
C03	`01`	`X`	`SPA`	`@0 Parkinson enfermedad @5 01`
C03	`02`	`X`	`FRE`	`@0 Récepteur dopaminergique D2 @5 04`
C03	`02`	`X`	`ENG`	`@0 D2 Dopamine receptor @5 04 @6 «D2» Dopamine receptor`
C03	`02`	`X`	`SPA`	`@0 Receptor dopaminérgico D2 @5 04`
C03	`03`	`X`	`FRE`	`@0 Corps strié @5 07`
C03	`03`	`X`	`ENG`	`@0 Corpus striatum @5 07`
C03	`03`	`X`	`SPA`	`@0 Cuerpo estriado @5 07`
C03	`04`	`X`	`FRE`	`@0 Tomoscintigraphie @5 10`
C03	`04`	`X`	`ENG`	`@0 Emission tomography @5 10`
C03	`04`	`X`	`SPA`	`@0 Tomocentelleografía @5 10`
C03	`05`	`X`	`FRE`	`@0 Positon @5 11`
C03	`05`	`X`	`ENG`	`@0 Positron @5 11`
C03	`05`	`X`	`GER`	`@0 Positron @5 11`
C03	`05`	`X`	`SPA`	`@0 Positrón @5 11`
C03	`06`	`X`	`FRE`	`@0 Raclopride @2 NK @2 FR @5 13`
C03	`06`	`X`	`ENG`	`@0 Raclopride @2 NK @2 FR @5 13`
C03	`06`	`X`	`SPA`	`@0 Racloprida @2 NK @2 FR @5 13`
C03	`07`	`X`	`FRE`	`@0 Neuroleptique @5 14`
C03	`07`	`X`	`ENG`	`@0 Neuroleptic @5 14`
C03	`07`	`X`	`SPA`	`@0 Neuroléptico @5 14`
C03	`08`	`X`	`FRE`	`@0 Psychotrope @2 FX @5 15`
C03	`08`	`X`	`ENG`	`@0 Psychotropic @2 FX @5 15`
C03	`08`	`X`	`SPA`	`@0 Psicotropo @2 FX @5 15`
C03	`09`	`X`	`FRE`	`@0 Antagoniste dopamine @5 16`
C03	`09`	`X`	`ENG`	`@0 Dopamine antagonist @5 16`
C03	`09`	`X`	`SPA`	`@0 Antagonista dopamina @5 16`
C03	`10`	`X`	`FRE`	`@0 Exploration @5 17`
C03	`10`	`X`	`ENG`	`@0 Exploration @5 17`
C03	`10`	`X`	`SPA`	`@0 Exploración @5 17`
C03	`11`	`X`	`FRE`	`@0 Homme @5 20`
C03	`11`	`X`	`ENG`	`@0 Human @5 20`
C03	`11`	`X`	`SPA`	`@0 Hombre @5 20`
C03	`12`	`X`	`FRE`	`@0 Long terme @5 23`
C03	`12`	`X`	`ENG`	`@0 Long term @5 23`
C03	`12`	`X`	`SPA`	`@0 Largo plazo @5 23`
C07	`01`	`X`	`FRE`	`@0 Système nerveux pathologie @5 37`
C07	`01`	`X`	`ENG`	`@0 Nervous system diseases @5 37`
C07	`01`	`X`	`SPA`	`@0 Sistema nervioso patología @5 37`
C07	`02`	`X`	`FRE`	`@0 Système nerveux central pathologie @5 38`
C07	`02`	`X`	`ENG`	`@0 Central nervous system disease @5 38`
C07	`02`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 38`
C07	`03`	`X`	`FRE`	`@0 Encéphale pathologie @5 39`
C07	`03`	`X`	`ENG`	`@0 Cerebral disorder @5 39`
C07	`03`	`X`	`SPA`	`@0 Encéfalo patología @5 39`
C07	`04`	`X`	`FRE`	`@0 Extrapyramidal syndrome @5 40`
C07	`04`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 40`
C07	`04`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 40`
C07	`05`	`X`	`FRE`	`@0 Maladie dégénérative @5 41`
C07	`05`	`X`	`ENG`	`@0 Degenerative disease @5 41`
C07	`05`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 41`
C07	`06`	`X`	`FRE`	`@0 Exploration radioisotopique @5 61`
C07	`06`	`X`	`ENG`	`@0 Radionuclide study @5 61`
C07	`06`	`X`	`SPA`	`@0 Exploración radioisotópica @5 61`
N21				`@1 062`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003304

Links to Exploration step

Pascal:97-0142918

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Long-term changes of striatal dopamine D<sub>2</sub>
 receptors in patients with Parkinson's disease : A study with positron emission tomography and [<sup>11</sup>
C]raclopride</title>
<author><name sortKey="Antonini, A" sort="Antonini, A" uniqKey="Antonini A" first="A." last="Antonini">A. Antonini</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>PET Department, Paul Scherrer Institute</s1>
<s2>Villigen</s2>
<s3>CHE</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
</affiliation>
</author>
<author><name sortKey="Schwarz, J" sort="Schwarz, J" uniqKey="Schwarz J" first="J." last="Schwarz">J. Schwarz</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Neurology, University Hospital Zurich</s1>
<s2>Zurich</s2>
<s3>CHE</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
</affiliation>
</author>
<author><name sortKey="Oertel, W H" sort="Oertel, W H" uniqKey="Oertel W" first="W. H." last="Oertel">W. H. Oertel</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Neurology, University Hospital Zurich</s1>
<s2>Zurich</s2>
<s3>CHE</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
</affiliation>
</author>
<author><name sortKey="Pogarell, O" sort="Pogarell, O" uniqKey="Pogarell O" first="O." last="Pogarell">O. Pogarell</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Neurology, University Hospital Zurich</s1>
<s2>Zurich</s2>
<s3>CHE</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
</affiliation>
</author>
<author><name sortKey="Leenders, K L" sort="Leenders, K L" uniqKey="Leenders K" first="K. L." last="Leenders">K. L. Leenders</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>PET Department, Paul Scherrer Institute</s1>
<s2>Villigen</s2>
<s3>CHE</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Neurology, Klinikum Grosshadern, Ludowig-Maximilians University</s1>
<s2>Munich</s2>
<s3>DEU</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">97-0142918</idno>
<date when="1997">1997</date>
<idno type="stanalyst">PASCAL 97-0142918 INIST</idno>
<idno type="RBID">Pascal:97-0142918</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">003304</idno>
<idno type="wicri:Area/PascalFrancis/Curation">003520</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Long-term changes of striatal dopamine D<sub>2</sub>
 receptors in patients with Parkinson's disease : A study with positron emission tomography and [<sup>11</sup>
C]raclopride</title>
<author><name sortKey="Antonini, A" sort="Antonini, A" uniqKey="Antonini A" first="A." last="Antonini">A. Antonini</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>PET Department, Paul Scherrer Institute</s1>
<s2>Villigen</s2>
<s3>CHE</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
</affiliation>
</author>
<author><name sortKey="Schwarz, J" sort="Schwarz, J" uniqKey="Schwarz J" first="J." last="Schwarz">J. Schwarz</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Neurology, University Hospital Zurich</s1>
<s2>Zurich</s2>
<s3>CHE</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
</affiliation>
</author>
<author><name sortKey="Oertel, W H" sort="Oertel, W H" uniqKey="Oertel W" first="W. H." last="Oertel">W. H. Oertel</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Neurology, University Hospital Zurich</s1>
<s2>Zurich</s2>
<s3>CHE</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
</affiliation>
</author>
<author><name sortKey="Pogarell, O" sort="Pogarell, O" uniqKey="Pogarell O" first="O." last="Pogarell">O. Pogarell</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Neurology, University Hospital Zurich</s1>
<s2>Zurich</s2>
<s3>CHE</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
</affiliation>
</author>
<author><name sortKey="Leenders, K L" sort="Leenders, K L" uniqKey="Leenders K" first="K. L." last="Leenders">K. L. Leenders</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>PET Department, Paul Scherrer Institute</s1>
<s2>Villigen</s2>
<s3>CHE</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Neurology, Klinikum Grosshadern, Ludowig-Maximilians University</s1>
<s2>Munich</s2>
<s3>DEU</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1997">1997</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Corpus striatum</term>
<term>D2 Dopamine receptor</term>
<term>Dopamine antagonist</term>
<term>Emission tomography</term>
<term>Exploration</term>
<term>Human</term>
<term>Long term</term>
<term>Neuroleptic</term>
<term>Parkinson disease</term>
<term>Positron</term>
<term>Psychotropic</term>
<term>Raclopride</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Récepteur dopaminergique D2</term>
<term>Corps strié</term>
<term>Tomoscintigraphie</term>
<term>Positon</term>
<term>Raclopride</term>
<term>Neuroleptique</term>
<term>Psychotrope</term>
<term>Antagoniste dopamine</term>
<term>Exploration</term>
<term>Homme</term>
<term>Long terme</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>12</s2>
</fA05>
<fA06><s2>1</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Long-term changes of striatal dopamine D<sub>2</sub>
 receptors in patients with Parkinson's disease : A study with positron emission tomography and [<sup>11</sup>
C]raclopride</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>ANTONINI (A.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>SCHWARZ (J.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>OERTEL (W. H.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>POGARELL (O.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>LEENDERS (K. L.)</s1>
</fA11>
<fA14 i1="01"><s1>PET Department, Paul Scherrer Institute</s1>
<s2>Villigen</s2>
<s3>CHE</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Department of Neurology, University Hospital Zurich</s1>
<s2>Zurich</s2>
<s3>CHE</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Neurology, Klinikum Grosshadern, Ludowig-Maximilians University</s1>
<s2>Munich</s2>
<s3>DEU</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA20><s1>33-38</s1>
</fA20>
<fA21><s1>1997</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000062292810050</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 1997 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>23 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>97-0142918</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC02 i1="01" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Récepteur dopaminergique D2</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>D2 Dopamine receptor</s0>
<s5>04</s5>
<s6>«D2» Dopamine receptor</s6>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Receptor dopaminérgico D2</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Corps strié</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Corpus striatum</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Cuerpo estriado</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Tomoscintigraphie</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Emission tomography</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Tomocentelleografía</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Positon</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Positron</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="GER"><s0>Positron</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Positrón</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Raclopride</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Raclopride</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Racloprida</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Neuroleptique</s0>
<s5>14</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Neuroleptic</s0>
<s5>14</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Neuroléptico</s0>
<s5>14</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Psychotrope</s0>
<s2>FX</s2>
<s5>15</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Psychotropic</s0>
<s2>FX</s2>
<s5>15</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Psicotropo</s0>
<s2>FX</s2>
<s5>15</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Antagoniste dopamine</s0>
<s5>16</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Dopamine antagonist</s0>
<s5>16</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Antagonista dopamina</s0>
<s5>16</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Exploration</s0>
<s5>17</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Exploration</s0>
<s5>17</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Exploración</s0>
<s5>17</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Homme</s0>
<s5>20</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Human</s0>
<s5>20</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Hombre</s0>
<s5>20</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Long terme</s0>
<s5>23</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Long term</s0>
<s5>23</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Largo plazo</s0>
<s5>23</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Exploration radioisotopique</s0>
<s5>61</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Radionuclide study</s0>
<s5>61</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Exploración radioisotópica</s0>
<s5>61</s5>
</fC07>
<fN21><s1>062</s1>
</fN21>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003520 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 003520 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:97-0142918
   |texte=   Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease : A study with positron emission tomography and [11C]raclopride
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease : A study with positron emission tomography and [11C]raclopride

Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease : A study with positron emission tomography and [11C]raclopride

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri